Duration and Life-Stage of Antibiotic Use and Risks of All-Cause and Cause-Specific Mortality: Prospective Cohort Study.

Circ Res
Authors
Abstract

The overuse of antibiotics has been an important clinical issue, and antibiotic exposure is linked to alterations in gut microbiota, which has been related to risks of various chronic diseases such as cardiovascular disease and cancer. Also, duration of antibiotic exposure may be a risk factor of premature death. We investigated associations of life-stage and duration of antibiotic use during adulthood with risks of all-cause and cause-specific mortality. This prospective cohort study included 37 516 women aged ≥60 years who were free of cardiovascular disease or cancer from the Nurses' Health Study. Participants reported a total amount of time they used antibiotics (none, 15 days, 15 days to 2 months, or ≥2 months) in the middle- (age, 40-59) and late adulthood (age, 60 or older). We estimated hazard ratios for all-cause mortality and deaths from cardiovascular disease or cancer over 10 years according to duration of antibiotic use. During 355 918 person-years of follow-up, we documented 4536 deaths from any cause (including 728 cardiovascular deaths and 1206 cancer deaths). As compared with women who did not use antibiotics, those who used them for ≥2 months in late adulthood had increased risks of all-cause mortality (hazard ratio, 1.16 [95% CI, 1.01-1.33]) and cardiovascular mortality (hazard ratio, 1.49 [95% CI, 1.04-2.13]), but not cancer mortality (hazard ratio, 0.85 [95% CI, 0.65-1.12]) after adjustment for chronic metabolic diseases, antibiotic use during middle adulthood, indication for use, demographic factors, and lifestyle/dietary factors. The association was more evident among women who also used antibiotics in middle-adulthood than among those who did not use during this life-stage. Long-term use of antibiotics in late adulthood may be a risk factor for all-cause and cardiovascular mortality. The unfavorable effect of antibiotic exposure for subsequent risks of deaths due to chronic diseases needs to be considered.

Year of Publication
2020
Journal
Circ Res
Volume
126
Issue
3
Pages
364-373
Date Published
2020 Jan 31
ISSN
1524-4571
DOI
10.1161/CIRCRESAHA.119.315279
PubMed ID
31842690
PubMed Central ID
PMC7046316
Links
Grant list
R01 DK078616 / DK / NIDDK NIH HHS / United States
P01 CA087969 / CA / NCI NIH HHS / United States
R01 DK115679 / DK / NIDDK NIH HHS / United States
R01 DK091718 / DK / NIDDK NIH HHS / United States
R01 CA137178 / CA / NCI NIH HHS / United States
R21 HL126024 / HL / NHLBI NIH HHS / United States
R01 HL071981 / HL / NHLBI NIH HHS / United States
R01 HL088521 / HL / NHLBI NIH HHS / United States
R21 TW010790 / TW / FIC NIH HHS / United States
P30 DK046200 / DK / NIDDK NIH HHS / United States
K24 DK098311 / DK / NIDDK NIH HHS / United States
R01 HL034594 / HL / NHLBI NIH HHS / United States
UM1 CA186107 / CA / NCI NIH HHS / United States
U01 DK078616 / DK / NIDDK NIH HHS / United States
R01 DK100383 / DK / NIDDK NIH HHS / United States